Skip to main content
Erschienen in: Acta Neurochirurgica 12/2020

Open Access 10.07.2020 | Review Article - Neurosurgical technique evaluation

The IDEAL framework in neurosurgery: a bibliometric analysis

verfasst von: Helen C. U. Ota, Brandon G. Smith, Alexander Alamri, Faith C. Robertson, Hani Marcus, Allison Hirst, Marike Broekman, Peter Hutchinson, Peter McCulloch, Angelos Kolias

Erschienen in: Acta Neurochirurgica | Ausgabe 12/2020

Abstract

Background

The Idea, Development, Exploration, Assessment and Long-term study (IDEAL) framework was created to provide a structured way for assessing and evaluating novel surgical techniques and devices.

Objectives

The aim of this paper was to investigate the utilization of the IDEAL framework within neurosurgery, and to identify factors influencing implementation.

Methods

A bibliometric analysis of the 7 key IDEAL papers on Scopus, PubMed, Embase, Web of Science, and Google Scholar databases (2009–2019) was performed. A second journal-specific search then identified additional papers citing the IDEAL framework. Publications identified were screened by two independent reviewers to select neurosurgery-specific articles.

Results

The citation search identified 1336 articles. The journal search identified another 16 articles. Following deduplication and review, 51 relevant articles remained; 14 primary papers (27%) and 37 secondary papers (73%). Of the primary papers, 5 (36%) papers applied the IDEAL framework to their research correctly; two were aligned to the pre-IDEAL stage, one to the Idea and Development stages, and two to the Exploration stage. Of the secondary papers, 21 (57%) explicitly discussed the IDEAL framework. Eighteen (86%) of these were supportive of implementing the framework, while one was not, and two were neutral.

Conclusion

The adoption of the IDEAL framework in neurosurgery has been slow, particularly for early-stage neurosurgical techniques and inventions. However, the largely positive reviews in secondary literature suggest potential for increased use that may be achieved with education and publicity.
Hinweise
This article is part of the Topical Collection on Neurosurgical technique evaluation
Comments
The IDEAL framework represents a set of steps whose goal is that of generating sound innovations in Surgery while assuring adequate ethics and patient awareness compliance. These recommendations were first published in 2009 following a series of meetings at Balliol College, Oxford, during 2007 to 2009 to discuss the specific challenges of evaluating surgical innovation (1).
A review of the evolving IDEAL recommendations is provided by Hirst et al. in 2019 (2). The paper by CU Ota et al analyzes the penetration of the Ideal framework in Neurosurgical publications. It identifies primary papers where an attempt is made to follow Ideal recommendations in the construction of the study and secondary papers in which the Ideal recommendations are discussed in the text or simply mentioned in the Reference section.
The results show a low penetration of the IDEAL instrument with 14 primary papers and 37 secondary papers representing 4% of a total of 1336 articles evaluated.
The authors suggest a number of reasons for this low uptake including overreliance on time-honored retrospective case series and lack of awareness of the IDEAL concept, including a few studies which in practicality conform to IDEAL recommendations but fail to mention them. While these explanations may play a more or less relevant role, a perhaps bigger role may be linked to the over-enthusiasm of the surgical innovator for her/his innovation that might not be validated if a more stringent evaluation, such as the IDEAL one, was to be sought.
What to do about the current situation? Demand more accountability on the proposed innovations, highlighting what the proposed innovation is going to ameliorate and what is the process chosen to validate it.
In this context, a more widespread use of the Ideal recommendations could be very useful.
We fully agree with the authors that a more robust education of the Neurosurgical community on the concept of the IDEAL recommendations is warranted and, we add, should be actively pursued by Neurosurgical Societies worldwide.
Mario Ammirati
PA, USA

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

With technological advances leading to rapid development of new devices and operative techniques, it remains imperative that we critically assess novel ideas to ensure they confer true patient benefit. Innovative solutions to unique problems are reliant on creativity and lateral thinking, which can appear at odds with the rules and regulations required to systematically appraise developments. However, it is in the interest of patient safety and the society to ensure that widespread implementation occurs after rigorous assessment and research [18].
The IDEAL framework is a straightforward and structured approach that can guide evaluation and research across all surgical fields, while also allowing enough flexibility to prevent stifling of innovation. First published in 2009 [41], it was developed to provide guidance on the evaluation of surgical techniques and devices from inception to long-term evaluation [7]. It consists of 5 stages: Idea, Development, Exploration, Assessment, and Long-term studies. Each stage includes various recommendations to ensure that high-quality evidence is obtained when studying new ideas, as demonstrated in Table 1.
Table 1
Table outlining the IDEAL framework recommendations (adapted with permission from the authors)[25]
 
1 Idea
2a Development
2b Exploration
3 Assessment
4 Long-term study
Purpose
Proof of concept
Development
Learning
Assessment
Surveillance
Number and types of patients
Single digit; highly selected
Few; selected
Many; may expand to mixed; broadening indication
Many; expanded indications (well defined)
All eligible
Number and types of surgeons
Very few; innovators
Few; innovators and some early adopters
Many; innovators, early adopters, early majority
Many; early majority
All eligible
Output
Description
Description
Measurement; compassion
Comparison; complete information for non-RCT participants
Description; audit, regional variation; quality assurance; risk adjustment
Intervention
Evolving; procedure inception
Evolving; procedure development
Evolving; procedure refinement, community learning
Stable
Stable
Method
Structured case reports
Prospective development studies
Research database; explanatory or feasibility RCT (efficacy trial); diseased based (diagnostic)
RCT with or without additions/modifications; alternative designs
Registry; routine database
Outcomes
Proof of concept; technical achievement; disasters; dramatic successes
Mainly safety; technical and procedural success
Safety; clinical outcomes (specific and graded); short-term outcomes; patient-centred (reported) outcomes; feasibility outcomes
Clinical outcomes (specific and graded); middle-term and long-term outcomes; patient-centered (reported) outcomes; cost-effectiveness
Rare events; long-term outcomes; quality assurance
Ethical approval
Sometimes
Yes
Yes
Yes
No
This framework differs from the traditional model of pharmacological trials to accommodate the distinct way surgical developments occur, particularly since individual operator skill and technique modifications at the early stages can differentially impact outcomes.[46]. A subsequent paper introduced Stage 0, a preclinical stage, for testing involving cadavers, animals, or simulations, while another clarified the use of the IDEAL framework in surgical device development [25, 56]. The IDEAL structure adds value to surgical innovation by ensuring safety and regulation; however, uptake has varied across various countries and surgical specialties. While utilization has increased overall, this has predominantly happened in other surgical fields [28]. A recent review of the IDEAL framework applied within minimally invasive neurosurgical research assessed historical studies involved in the development of the endoscopic endonasal approach for skull base meningiomas and the Woven EndoBridge (WEB) device for endovascular treatment of intracranial aneurysms [48]. The authors assessed the quality of the research that contributed to these developments by measuring the adherence of various studies to IDEAL guidelines. Their search revealed a total of four clinical papers that could be aligned with any stage of the IDEAL framework.
The aim of this bibliometric review is to investigate the adoption of the IDEAL framework in neurosurgical literature as a whole and reflect on factors influencing implementation since its inception 10 years ago.

Methodology

We performed individual citation searches for the seven main IDEAL papers [13, 18, 19, 25, 41, 42, 56] on Scopus, PubMed, Embase, Web of Science, and Google Scholar databases (September 2009 to August 2019). Articles were identified and analyzed by two independent reviewers, CO and BS. These searches were completed on each database individually. Papers identified were stored and deduplicated in Mendeley reference manager. The titles and abstracts of all papers were then screened for relevance to the study by the two independent reviewers, followed by full text review; the final selection was reviewed by a third independent reviewer to ensure suitability for inclusion (AA). Any disagreements were resolved following discussion with the senior author (AK). All papers with a focus on neurosurgical techniques or devices published between September 2009 and August 2019 were included. Non-English papers and non-journal text (such as book chapters) were excluded. This methodology was first used by Tradewell et al., investigating the use of the IDEAL framework in urological research [57].
For completeness, a second search using the terms “IDEAL Collaboration” and “IDEAL framework” was performed in the following major neurosurgical journals: Acta Neurochirurgica, British Journal of Neurosurgery, Child’s Nervous System, Clinical Neurology and Neurosurgery, Journal of Clinical Neuroscience, Journal of Korean Neurosurgical Society, Journal of Neurology, Neurosurgery and Psychiatry, Journal of Neurosurgery, Journal of Neurosurgery: Pediatrics, Journal of Neurosurgery: Spine, Journal of Neurosurgical Sciences, Neurosurgery, Neurosurgery Clinics of North America and Clinical Neurosurgery, Neurosurgical Focus, Neurosurgical Review, Pediatric Neurosurgery, Stereotactic and Functional Neurosurgery, Turkish Neurosurgery, and World Neurosurgery.
Primary papers were defined as original research publications assessing new surgical techniques or devices, and were linked to the most relevant stage of the IDEAL protocol (many self-identified) and assessed for adherence to criteria for that stage. Secondary papers included systematic reviews, opinion pieces, and letters to the editor; these were assessed with regard to their support for and evaluation of the IDEAL papers and framework.

Results

The citation search identified 1336 articles, while the secondary search identified another 16 (see Fig. 1). Following deduplication and abstract review, 51 relevant articles were identified. Thereafter remained fourteen primary papers [8, 17, 20, 26, 33, 34, 37, 39, 46, 51, 55, 5860], and 37 secondary papers [15, 912, 1416, 23, 27, 2932, 35, 36, 38, 40, 4345, 4750, 5254, 57, 62, 6466].
Articles were published from 2010 to July 2019 (date of citation search), with a peak in 2018. The top 3 journals for publications that cited the IDEAL articles were Acta Neurochirurgica (n = 8), Journal of Neurosurgery (n = 5), and World Neurosurgery (n = 5).

Primary publication analysis

All of the fourteen primary publications identified were from European groups. Papers were published between 2013 and 2019 and spanned a number of sub-specialties including skull base, neuro-oncology, and spinal neurosurgery. Ten papers (71%) explicitly mention the IDEAL framework within their text [8, 20, 26, 33, 34, 37, 39, 55, 58, 60]. Six (43%) papers aimed to align their research with a specific stage of the IDEAL framework [8, 20, 33, 34, 39, 60]. Of these six, five (83%) papers appropriately applied the IDEAL framework to their research; one publication claiming to align to stage 1/2a was an animal study [8]. Animal studies are technically stage 0, the preclinical stage of the IDEAL framework [33].
Of the five papers appropriately staged, their adherence to IDEAL recommendation including study size, ethical oversight, and outcome measures are presented in Table 2.
Table 2
Publication adherence to IDEAL framework (N/A refers to criteria not necessary to fulfill a specific stage of the IDEAL framework)
 
Belotti et al.[8]
Versteeg et al.[60]
Majovsky et al.[34]
Flores et al.[20]
Marcus et al.[39]
IDEAL stage
0
1/2a
2a
2a
0 (Ideal-D)
Study Size (Mean)
10 specimen
3 (Stage 1), 10 (Stage 2a)
18
30
15
Follow up time (months, mean)
N/A
13
9.3
6.5
N/A
Number of surgeons reported (number of surgeons)
No (N/A)
No (N/A)
No (N/A)
No (N/A)
Yes (4)
Number of clinical sites reported (mean number of clinical sites)
Yes (2)
Yes (1)
No (N/A)
No (N/A)
Yes (1)
Prospective study
N/A
Yes
Yes
No
N/A
Prior published/registered protocol
N/A
N/A
No
No
N/A
Safety/feasibility of procedure considered
Yes
N/A
N/A
Yes
Yes
Ethical oversight
N/A
Yes
No
No
N/A
Document adverse outcomes
N/A
Yes
Yes
Yes
N/A
Sequential reporting of outcomes
N/A
Yes
Yes
Yes
N/A
Patient reported outcomes
N/A
No
Yes
Yes
N/A
Participants registered in a database
N/A
No
No
No
N/A
Surgeons view of procedures considered
N/A
No
N/A
No
N/A
Documented funding
No
Yes
Yes
No
Yes
The paper by Belotti et al. aligned with Stage 0, the preclinical stage of the IDEAL framework [8]. This study involved the use of 10 specimens for testing in one clinical center, another two for filming in a second center. The purpose of the study was to improve safety and effectiveness of the transsphenoidal approach by categorizing different approaches, aligning with Stage 0. Marcus et al. also aligned their study to Stage 0, within the IDEAL-D framework specific to devices; comparing the use of computer-assisted planning with manual planning in stereotactic brain biopsy [39]. The study by Versteeg et al. that investigated spinal stabilization following radiotherapy had two arms. Each arm was applied appropriately to the Idea (1) and Development (2a) stages with samples sizes of 3 and 10, respectively [60]. Adverse events were evaluated and classified according to the common toxicity criteria adverse events during a median clinical follow-up time of 13 months. The study by Majovsky et al. was stage 2a and assessed the use of burr holes in evacuation of chronic subdural hematomas [34]. The paper by Flores et al. was also aligned to stage 2a, investigating the use of syringes as dilators and retractors in spinal surgery in 30 patients [20]. None of the studies included from the citation search identified as stage 2b, 3, or 4 (exploration, assessment, long-term monitoring).

Secondary publication analysis

Thirty-seven secondary papers were identified. Of them, 13 (35%) were narrative reviews [9, 11, 15, 27, 2931, 4345, 52, 53, 64]. Eleven (30%) were systematic reviews [1, 5, 10, 14, 16, 38, 40, 46, 48, 49, 66].
The remaining papers identified are consist of 10 letters to the editor (27%) [24, 12, 23, 32, 36, 47, 50, 54], 2 questionnaire-based analyses (one exploring views on the use of evidence-based medicine principles in neurosurgery, the other seeking to understand the neurosurgical definition of “innovation”) [62, 65], and 1 article outlining the work of the British Neurosurgical Trainee Collaborative [57].
Of the secondary publications, 21 (57%) explicitly mentioned the IDEAL framework [1, 3, 5, 1012, 14, 15, 29, 32, 38, 43, 4750, 52, 53, 57, 60, 65], while the rest cited the IDEAL publications, but did not discuss them. Of the 21 papers that discussed the IDEAL framework, 18 (86%) were supportive of the use of the IDEAL framework [3, 5, 1012, 14, 15, 29, 32, 38, 43, 47, 49, 50, 52, 53, 57, 60], while 1 paper was not [1], and 2 were neutral [48, 65]. Six of these publications evaluated the applicability of the IDEAL framework in neurosurgical innovation [38, 47, 48, 50, 64, 65].

Discussion

The aim of this study was to explore the adoption of the IDEAL framework within neurosurgery by reviewing citations of the key IDEAL papers. The citation search allowed us to assess awareness of the framework, and examine the way in which it is utilized. This methodology was informed by the work of Tradewell et al. who also used a citation search to review the use of the IDEAL framework in urological literature [21]. Given the large number of citations of these papers in urological literature, it is clear that the framework has impacted thinking in surgical development; however, this does not seem to be reflected particularly in neurosurgery, evident by the small number of papers that specifically cited the framework, or were aligned to a specific stage of the framework. Encouragingly, the number of neurosurgical papers referencing the framework has shown a year on year increase; however, numbers remain relatively small.
There are several factors that could contribute to the limited uptake of the IDEAL framework in neurosurgery. A potential cause is a lack of awareness. The IDEAL framework was developed in the UK, and initially published in 2009 [41]. Though there are a number of articles that outline the IDEAL framework and its recommendations, it is possible that those involved in current research and surgical development are either not aware, or not particularly well versed in the framework. This is supported by our finding that all primary papers were of European origin. It is also important to consider that many researchers may not have considered the need for a framework specifically designed for surgical innovation, and therefore did not seek one out. Given the low numbers of primary papers that cited and applied the IDEAL framework to their research, and given that some of these papers did so incorrectly or incompletely, it is clear that education on the IDEAL framework is still actively required to guide researchers and authors, a problem also identified by Khachane et al. [28]. The IDEAL council has identified this potential issue, and encourages surgeons from all specialties and any country to join the collaboration, particularly through the use of a diverse group of council advisors and specialty leads from a number of different countries and specialties, who help to develop and promote the IDEAL framework. The IDEAL council view the framework as ever-evolving in response to pragmatic need and a requirement to learn from IDEAL’s end-users. The update paper was also published in the Annals of Surgery, a US Journal, to further increase the reach of the framework [25].
It is also important to consider how applicable the framework is to neurosurgical research. Surgical innovation and technical development differ between specialties and even sub-specialties, as illustrated in Muskens et al.’s examination of innovation within endoscopic endonasal surgery for skull base meningiomas versus the Woven EndoBridge device for endovascular treatment of intracranial aneurysms. When they explored mapping those developments to the IDEAL framework, only four of the 21 papers included could be matched to any stage of the IDEAL framework: two papers to Stage 2A and two to 2B [48]. Looking specifically at the lack of papers that align with stage 2B, as replicated by our own results, a potential reason for the low numbers of this type of study is that neurosurgical research still largely follows the traditional model of a phase 2 randomized trial that may or may not be followed by a phase 3 randomized trial. A recent example is the MISTIE II and MISTIE III trials (phase 2 and phase 3 trials), which evaluated a new technique for evacuation of intracerebral hemorrhage (ICH) [22, 63]. Given these studies fulfill much of the criteria for IDEAL stages 2b and 3, it is clear that potential to align these studies is the IDEAL framework is present; however, tradition or simply lack of awareness of the IDEAL framework may have prevented this.
Another potential reason is that, as is often the case with surgical research, there is an overreliance on retrospective “case series.” This is likely because case series are easy to perform, require less resources, can be conducted at a single center, and, for many surgeons, are means to showcase their surgical skills and outcomes [61]. Furthermore these studies afford a flexibility that may not be afforded by adhering strictly to the IDEAL framework. Some surgeons would argue that limiting this flexibility stifles innovation. However, the true aim of the framework is to facilitate the conduct of well-designed and well-executed studies in order to facilitate the adoption of innovative techniques, if found to be effective. A recent example is the use of middle meningeal artery (MMA) embolization for chronic subdural hematomas (CSDH), where the majority of conducted studies are case series [6]. Although this procedure is clearly innovative, many of the studies reported use of MMA embolization for atypical indications (e.g., asymptomatic patients, as “prophylaxis” after surgery) outside the context of ethically approved research.
The lack of IDEAL stage 3 studies, which are typically a definitive, multi-center randomized trial, can be explained by the fact that these studies are usually identified as phase 3 trials or simply randomized trials, despite technically meeting the criteria of a stage 3 IDEAL study. A recent review identified 401 published randomized trials on brain and spine conditions treated by neurosurgeons from 2003 to 2016 [24]. Given these numbers, it appears that randomized trials are possible within neurosurgical innovation, and therefore the potential for stage 2b and stage 3 IDEAL studies is much greater than what is currently present. In order to investigate this further, qualitative feedback should be sought from neurosurgeons on the applicability of the IDEAL framework to their research, in order to identify factors that have limited or prevented use. This information may in turn be used to guide future updates of the framework, and educational materials used within the neurosurgical community.
As most developments occur in incremental improvements upon techniques or devices, the appropriateness of large randomized controlled trials for each small, additive change is questionable. However, this would not apply to innovations, such as MMA embolization or the MISTIE procedure, which are entirely different to the usual method of treating CSDH and ICH, respectively [21, 22, 61]. There are also ethical considerations; if a new technique or surgical device displays a substantial, unequivocal benefit over past standard (e.g. the introduction of microscope in micro-neurosurgery), the lack of clinical equipoise precludes conducting a trial that may expose patients to suboptimal treatment.
There are also ongoing concerns that neurosurgical randomized trials are often not feasible or impractical [64]. Some authors suggest that routinely collected or observational data can lead to robust conclusions regarding the comparative effectiveness of treatment; however, this is a relatively new field with ongoing methodological challenges. As an example, a recent study found that observational studies based on routinely collected health data could give different answers from subsequent randomized trials on the same clinical questions and may substantially overestimate treatment effects [6]. Reasons for this are likely multiple, and while this difference could reflect a difference in validity achieved by the different study methodologies, it is important to consider the impact the highly selective populations used for randomized trials could have on research outcomes, in comparison with the broader populations that usually contribute to observational studies. Another option, which is gaining traction in recent years, is the use of pragmatic large randomized trials that have broad inclusion criteria in order to reflect real-world practice. The IDEAL collaboration is working on developing guidance on the use of real-world evidence for the purposes of comparative effectiveness research.
The most recent IDEAL publication, a follow up to the first paper, has elaborated more on the recommendations and how to apply them for each stage [25]. It is hoped that this new update of the IDEAL framework will improve the understanding of where the framework can fit within neurosurgery and therefore improve uptake. Further projects include stage-specific reporting guidelines developed using Delphi methodology. Given that the majority of secondary papers that cited the IDEAL framework were supportive of its use, it would seem that education, promotion, and room for specialty-specific nuance within recommendations could largely improve uptake, and in turn help guide neurosurgical development to produce a high-quality evidence base for our practice.

Limitations of this paper

This paper reviewed articles that cited the IDEAL framework key papers. It is possible that there are studies that have adhered to and referenced the framework, but have not cited these papers and are therefore excluded from this review. The secondary journal specific search aimed to negate this limitation; however, this solely identified articles within the selection of journals searched (listed above). Papers published in other journals will not have been identified in this search. It is also possible that there is a research that has unintentionally adhered to the IDEAL framework but has not been included, again as they have not cited the IDEAL papers. Evaluation of the papers and their adherence to the IDEAL framework recommendation (primary papers) or support of the IDEAL framework (secondary papers) was subjective, as based on the opinion and understanding of the authors of this paper.

Conclusion

Ultimately, in order to fully evaluate the potential for the IDEAL framework in neurosurgical research, it is necessary that more primary research studies attempt to follow the recommendations. Feedback highlighting neurosurgery-specific limitations can be generated and incorporated into future iterations of the framework. This will ensure that it is able to support and work with nuances and specialty-specific concerns that are causing limited use of the IDEAL framework thus far.

Compliance with ethical standards

Conflict of interest

PH is supported by a Research Professorship from the National Institute for Health Research (NIHR), the NIHR Cambridge Biomedical Research Centre, an NIHR Senior Investigator award, a European Union Seventh Framework Program grant (CENTER-TBI; grant no. 602150), and the Royal College of Surgeons of England. AK is supported by a Clinical Lectureship, School of Clinical Medicine, University of Cambridge and the Royal College of Surgeons of England.
All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) in the subject matter or materials discussed in this manuscript. A number of authors are affiliated with the IDEAL collaboration, and therefore have a professional relationship with an organization with non-financial interest in this subject matter.

Ethical approval

For this type of study formal consent is not required.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.
Comments
The IDEAL framework represents a set of steps whose goal is that of generating sound innovations in Surgery while assuring adequate ethics and patient awareness compliance. These recommendations were first published in 2009 following a series of meetings at Balliol College, Oxford, during 2007 to 2009 to discuss the specific challenges of evaluating surgical innovation (1).
A review of the evolving IDEAL recommendations is provided by Hirst et al. in 2019 (2). The paper by CU Ota et al analyzes the penetration of the Ideal framework in Neurosurgical publications. It identifies primary papers where an attempt is made to follow Ideal recommendations in the construction of the study and secondary papers in which the Ideal recommendations are discussed in the text or simply mentioned in the Reference section.
The results show a low penetration of the IDEAL instrument with 14 primary papers and 37 secondary papers representing 4% of a total of 1336 articles evaluated.
The authors suggest a number of reasons for this low uptake including overreliance on time-honored retrospective case series and lack of awareness of the IDEAL concept, including a few studies which in practicality conform to IDEAL recommendations but fail to mention them. While these explanations may play a more or less relevant role, a perhaps bigger role may be linked to the over-enthusiasm of the surgical innovator for her/his innovation that might not be validated if a more stringent evaluation, such as the IDEAL one, was to be sought.
What to do about the current situation? Demand more accountability on the proposed innovations, highlighting what the proposed innovation is going to ameliorate and what is the process chosen to validate it.
In this context, a more widespread use of the Ideal recommendations could be very useful.
We fully agree with the authors that a more robust education of the Neurosurgical community on the concept of the IDEAL recommendations is warranted and, we add, should be actively pursued by Neurosurgical Societies worldwide.
Mario Ammirati
PA, USA

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Almutairi R, Muskens I, Cote D, Dijkman M, Kavouridis V, Crocker E, Ghazawi K, Broekman M, Smith T, Mekary R, Zaidi H (2018) Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir 160(5):1005–1021CrossRefPubMed Almutairi R, Muskens I, Cote D, Dijkman M, Kavouridis V, Crocker E, Ghazawi K, Broekman M, Smith T, Mekary R, Zaidi H (2018) Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir 160(5):1005–1021CrossRefPubMed
2.
Zurück zum Zitat Al-Shahi Salman R, Whittle I (2012) There is still Hope for surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke 43(6):1460–1461CrossRefPubMed Al-Shahi Salman R, Whittle I (2012) There is still Hope for surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke 43(6):1460–1461CrossRefPubMed
3.
Zurück zum Zitat Ammirati M (2017) Innovation in neurosurgery response to: “Ideal”, the operating microscope, and the parachute. Acta Neurochir 160(2):371–371CrossRefPubMed Ammirati M (2017) Innovation in neurosurgery response to: “Ideal”, the operating microscope, and the parachute. Acta Neurochir 160(2):371–371CrossRefPubMed
4.
Zurück zum Zitat Ammirati M, Ercan S (2017) Letter to the editor. Keyhole and standard subtemporal approaches. J Neurosurg 127(1):228–229CrossRef Ammirati M, Ercan S (2017) Letter to the editor. Keyhole and standard subtemporal approaches. J Neurosurg 127(1):228–229CrossRef
5.
Zurück zum Zitat Ammirati M, Wei L, Ciric I (2012) Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 84(8):843–849PubMedCrossRef Ammirati M, Wei L, Ciric I (2012) Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 84(8):843–849PubMedCrossRef
6.
Zurück zum Zitat Azad T, Veeravagu A, Mittal V, Esparza R, Johnson E, Ioannidis J, Grant G (2017) Neurosurgical randomized controlled trials—distance travelled. Neurosurgery 82(5):604–612CrossRef Azad T, Veeravagu A, Mittal V, Esparza R, Johnson E, Ioannidis J, Grant G (2017) Neurosurgical randomized controlled trials—distance travelled. Neurosurgery 82(5):604–612CrossRef
7.
Zurück zum Zitat Barkun J, Aronson J, Feldman L, Maddern G, Strasberg S (2009) Evaluation and stages of surgical innovations. Lancet 374(9695):1089–1096CrossRefPubMed Barkun J, Aronson J, Feldman L, Maddern G, Strasberg S (2009) Evaluation and stages of surgical innovations. Lancet 374(9695):1089–1096CrossRefPubMed
8.
Zurück zum Zitat Belotti F, Doglietto F, Schreiber A, Ravanelli M, Ferrari M, Lancini D, Rampinelli V, Hirtler L, Buffoli B, Bolzoni Villaret A, Maroldi R, Rodella L, Nicolai P, Fontanella M (2018) Modular classification of endoscopic endonasal transsphenoidal approaches to sellar region: anatomic quantitative study. World Neurosurgery 109:e281–e291CrossRefPubMed Belotti F, Doglietto F, Schreiber A, Ravanelli M, Ferrari M, Lancini D, Rampinelli V, Hirtler L, Buffoli B, Bolzoni Villaret A, Maroldi R, Rodella L, Nicolai P, Fontanella M (2018) Modular classification of endoscopic endonasal transsphenoidal approaches to sellar region: anatomic quantitative study. World Neurosurgery 109:e281–e291CrossRefPubMed
9.
Zurück zum Zitat Brastianos P, Galanis E, Butowski N, Chan J, Dunn I, Goldbrunner R, Herold-Mende C, Ippen F, Mawrin C, McDermott M, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn J, Wen P, Aldape K, Nassiri F, Zadeh G, Jenkinson M, Raleigh D, Aldape K, Au K, Barnhartz-Sloan J, Bi W, Brastianos P, Butowski N, Carlotti C, Cusimano M, DiMeco F, Drummond K, Dunn I, Galanis E, Giannini C, Goldbrunner R, Griffith B, Hashizume R, Hanemann C, Herold-Mende C, Horbinski C, Huang R, James D, Jenkinson M, Jungk C, Kaufman T, Krischek B, Lachance D, Lafougère C, Lee I, Liu J, Mamatjan Y, Mansouri A, Mawrin C, McDermott M, Munoz D, Nassiri F, Noushmehr H, Ng H, Perry A, Pirouzmand F, Poisson L, Pollo B, Raleigh D, Sahm F, Saladino A, Santarius T, Schichor C, Schultz D, Schmidt N, Selman W, Sloan A, Spears J, Snyder J, Suppiah S, Tabatabai G, Tatagiba M, Tirapelli D, Tonn J, Tsang D, Vogelbaum M, Deimling A, Wen P, Walbert T, Westphal M, Workewych A, Zadeh G (2019) Advances in multidisciplinary therapy for meningiomas. Neuro-oncology 21(Supplement_1):i18–i31PubMedPubMedCentralCrossRef Brastianos P, Galanis E, Butowski N, Chan J, Dunn I, Goldbrunner R, Herold-Mende C, Ippen F, Mawrin C, McDermott M, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn J, Wen P, Aldape K, Nassiri F, Zadeh G, Jenkinson M, Raleigh D, Aldape K, Au K, Barnhartz-Sloan J, Bi W, Brastianos P, Butowski N, Carlotti C, Cusimano M, DiMeco F, Drummond K, Dunn I, Galanis E, Giannini C, Goldbrunner R, Griffith B, Hashizume R, Hanemann C, Herold-Mende C, Horbinski C, Huang R, James D, Jenkinson M, Jungk C, Kaufman T, Krischek B, Lachance D, Lafougère C, Lee I, Liu J, Mamatjan Y, Mansouri A, Mawrin C, McDermott M, Munoz D, Nassiri F, Noushmehr H, Ng H, Perry A, Pirouzmand F, Poisson L, Pollo B, Raleigh D, Sahm F, Saladino A, Santarius T, Schichor C, Schultz D, Schmidt N, Selman W, Sloan A, Spears J, Snyder J, Suppiah S, Tabatabai G, Tatagiba M, Tirapelli D, Tonn J, Tsang D, Vogelbaum M, Deimling A, Wen P, Walbert T, Westphal M, Workewych A, Zadeh G (2019) Advances in multidisciplinary therapy for meningiomas. Neuro-oncology 21(Supplement_1):i18–i31PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Chari A, Kolias A, Santarius T, Bond S, Hutchinson P (2014) Twist-drill craniostomy with hollow screws for evacuation of chronic subdural hematoma. J Neurosurg 121(1):176–183CrossRefPubMed Chari A, Kolias A, Santarius T, Bond S, Hutchinson P (2014) Twist-drill craniostomy with hollow screws for evacuation of chronic subdural hematoma. J Neurosurg 121(1):176–183CrossRefPubMed
11.
Zurück zum Zitat Chari A, Hentall I, Papadopoulos M, Pereira E (2017) Surgical neurostimulation for spinal cord injury. Brain Sciences 7(12):18CrossRefPubMedCentral Chari A, Hentall I, Papadopoulos M, Pereira E (2017) Surgical neurostimulation for spinal cord injury. Brain Sciences 7(12):18CrossRefPubMedCentral
12.
13.
Zurück zum Zitat Cook J, McCulloch P, Blazeby J, Beard D, Marinac-Dabic D, Sedrakyan A (2013) IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 346(jun18 3):f2820–f2820PubMedPubMedCentralCrossRef Cook J, McCulloch P, Blazeby J, Beard D, Marinac-Dabic D, Sedrakyan A (2013) IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 346(jun18 3):f2820–f2820PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Corbett M, South E, Harden M, Eldabe S, Pereira E, Sedki I, Hall N, Woolacott N (2018) Brain and spinal stimulation therapies for phantom limb pain: a systematic review. Health Technol Assess 22(62):1–94PubMedPubMedCentralCrossRef Corbett M, South E, Harden M, Eldabe S, Pereira E, Sedki I, Hall N, Woolacott N (2018) Brain and spinal stimulation therapies for phantom limb pain: a systematic review. Health Technol Assess 22(62):1–94PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Doglietto F, Maira G (2013) Endoscopic Skull Base surgery: probably not the time for meta-analyses but certainly for prospectively collected data. World Neurosurgery 80(6):784–786CrossRefPubMed Doglietto F, Maira G (2013) Endoscopic Skull Base surgery: probably not the time for meta-analyses but certainly for prospectively collected data. World Neurosurgery 80(6):784–786CrossRefPubMed
16.
Zurück zum Zitat Doglietto F, Radovanovic I, Ravichandiran M, Agur A, Zadeh G, Qiu J, Kucharczyk W, Fernandez E, Fontanella M, Gentili F (2016) Quantification and comparison of neurosurgical approaches in the preclinical setting: literature review. Neurosurg Rev 39(3):357–368CrossRefPubMed Doglietto F, Radovanovic I, Ravichandiran M, Agur A, Zadeh G, Qiu J, Kucharczyk W, Fernandez E, Fontanella M, Gentili F (2016) Quantification and comparison of neurosurgical approaches in the preclinical setting: literature review. Neurosurg Rev 39(3):357–368CrossRefPubMed
17.
Zurück zum Zitat Doglietto F, Qiu J, Ravichandiran M, Radovanovic I, Belotti F, Agur A, Zadeh G, Fontanella M, Kucharczyk W, Gentili F (2017) Quantitative comparison of cranial approaches in the anatomy laboratory: a neuronavigation based research method. World Journal of Methodology 7(4):139–147PubMedPubMedCentralCrossRef Doglietto F, Qiu J, Ravichandiran M, Radovanovic I, Belotti F, Agur A, Zadeh G, Fontanella M, Kucharczyk W, Gentili F (2017) Quantitative comparison of cranial approaches in the anatomy laboratory: a neuronavigation based research method. World Journal of Methodology 7(4):139–147PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Ergina P, Cook J, Blazeby J, Boutron I, Clavien P, Reeves B, Seiler C (2009) Challenges in evaluating surgical innovation. Lancet 374(9695):1097–1104PubMedPubMedCentralCrossRef Ergina P, Cook J, Blazeby J, Boutron I, Clavien P, Reeves B, Seiler C (2009) Challenges in evaluating surgical innovation. Lancet 374(9695):1097–1104PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Ergina P, Barkun J, McCulloch P, Cook J, Altman D (2013) IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ 346(jun18 3):f3011–f3011PubMedPubMedCentralCrossRef Ergina P, Barkun J, McCulloch P, Cook J, Altman D (2013) IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ 346(jun18 3):f3011–f3011PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Flores R, Beltrán J, Ogando-Rivas E (2019) An affordable and feasible technique for minimally invasive tubular lumbar discectomy. World Neurosurgery 129:378–385CrossRefPubMed Flores R, Beltrán J, Ogando-Rivas E (2019) An affordable and feasible technique for minimally invasive tubular lumbar discectomy. World Neurosurgery 129:378–385CrossRefPubMed
21.
Zurück zum Zitat Hanley D, Thompson R, Muschelli J, Rosenblum M, McBee N, Lane K, Bistran-Hall A, Mayo S, Keyl P, Gandhi D, Morgan T, Ullman N, Mould W, Carhuapoma J, Kase C, Ziai W, Thompson C, Yenokyan G, Huang E, Broaddus W, Graham R, Aldrich E, Dodd R, Wijman C, Caron J, Huang J, Camarata P, Mendelow A, Gregson B, Janis S, Vespa P, Martin N, Awad I, Zuccarello M (2016) Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. The Lancet Neurology 15(12):1228–1237PubMedPubMedCentralCrossRef Hanley D, Thompson R, Muschelli J, Rosenblum M, McBee N, Lane K, Bistran-Hall A, Mayo S, Keyl P, Gandhi D, Morgan T, Ullman N, Mould W, Carhuapoma J, Kase C, Ziai W, Thompson C, Yenokyan G, Huang E, Broaddus W, Graham R, Aldrich E, Dodd R, Wijman C, Caron J, Huang J, Camarata P, Mendelow A, Gregson B, Janis S, Vespa P, Martin N, Awad I, Zuccarello M (2016) Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. The Lancet Neurology 15(12):1228–1237PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Hanley D, Thompson R, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo S, Bistran-Hall A, Gandhi D, Mould W, Ullman N, Ali H, Carhuapoma J, Kase C, Lees K, Dawson J, Wilson A, Betz J, Sugar E, Hao Y, Avadhani R, Caron J, Harrigan M, Carlson A, Bulters D, LeDoux D, Huang J, Cobb C, Gupta G, Kitagawa R, Chicoine M, Patel H, Dodd R, Camarata P, Wolfe S, Stadnik A, Money P, Mitchell P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum J, Wang W, Anderson C, Mendelow A, Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad I, Abdul-Rahim A, Abou-Hamden A, Abraham M, Ahmed A, Alba C, Aldrich E, Altschul D, Amin-Hanjani S, Anderson D, Ansari S, Antezana D, Ardelt A, Arikan F, Baguena M, Baker A, Barrer S, Becker K, Bergman T, Boström A, Braun J, Brindley P, Broaddus W, Brown R, Buki A, Cao B, Cao Y, Carrion-Penagos J, Chalela J, Chang T, Chorro I, Chowdhry S, Corral L, Csiba L, Davies J, Díaz A, Derdeyn C, Diringer M, Dlugash R, Ecker R, Economas T, Enriquez P, Ezer E, Fan Y, Feng H, Franz D, Freeman W, Fusco M, Galicich W, Gelea M, Goldstein J, Gonzalez A, Grabarits C, Greenberg S, Gress D, Gu E, Hall C, Hernandez F, Hoesch R, Hoh B, Houser J, Hu R, Huang Y, Hussain M, Insinga S, Jadhav A, Jaffe J, Jahromi B, Jallo J, James M, James R, Jankowitz B, Jeon E, Jichici D, Jonczak K, Jonker B, Karlen N, Keric N, Kerz T, Knopman J, Koenig C, Krishnamurthy S, Kumar A, Kureshi I, Laidlaw J, Lakhanpal A, Latorre J, Leifer D, Leiphart J, Lenington S, Li Y, Lopez G, Lovick D, Lumenta C, Luo J, Maas M, MacDonald J, MacKenzie L, Madan V, Majkowski R, Major O, Malhorta R, Malkoff M, Mangat H, Maswadeh A, Matouk C, McArthur K, McCaul S, Medow J, Mezey G, Mighty J, Miller D, Mohan K, Muir K, Muñoz L, Nakaji P, Nee A, Nekoovaght-Tak S, Nyquist P, O'Kane R, Okasha M, O'Kelly C, Ostapkovich N, Pandey A, Parry-Jones A, Perla K, Pollack A, Polster S, Pouratian N, Quinn T, Rajajee V, Reddy K, Rehman M, Reimer R, Rincon F, Rybinnik I, Sanchez B, Sansing L, Schneck M, Schuerer L, Schul D, Schweitzer J, Seder D, Seyfried D, Sheth K, Spiotta A, Stechison M, Szabo K, Tamayo G, Tanczos K, Taussky P, Terry J, Testai F, Thomas K, Thompson C, Thompson G, Torner J, Tran H, Tucker K, Ungar L, Varelas P, Vargas N, Vatter H, Venkatasubramanian C, Vermillion K, Vollmer D, Wang Y, Wang Y, Wen J, Whitworth L, Willis B, Wrencher M, Wright S, Xu Y, Yanase L, Yi X, Yu Z, Zomorodi A (2019) Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet 393(10175):1021–1032PubMedPubMedCentralCrossRef Hanley D, Thompson R, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo S, Bistran-Hall A, Gandhi D, Mould W, Ullman N, Ali H, Carhuapoma J, Kase C, Lees K, Dawson J, Wilson A, Betz J, Sugar E, Hao Y, Avadhani R, Caron J, Harrigan M, Carlson A, Bulters D, LeDoux D, Huang J, Cobb C, Gupta G, Kitagawa R, Chicoine M, Patel H, Dodd R, Camarata P, Wolfe S, Stadnik A, Money P, Mitchell P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum J, Wang W, Anderson C, Mendelow A, Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad I, Abdul-Rahim A, Abou-Hamden A, Abraham M, Ahmed A, Alba C, Aldrich E, Altschul D, Amin-Hanjani S, Anderson D, Ansari S, Antezana D, Ardelt A, Arikan F, Baguena M, Baker A, Barrer S, Becker K, Bergman T, Boström A, Braun J, Brindley P, Broaddus W, Brown R, Buki A, Cao B, Cao Y, Carrion-Penagos J, Chalela J, Chang T, Chorro I, Chowdhry S, Corral L, Csiba L, Davies J, Díaz A, Derdeyn C, Diringer M, Dlugash R, Ecker R, Economas T, Enriquez P, Ezer E, Fan Y, Feng H, Franz D, Freeman W, Fusco M, Galicich W, Gelea M, Goldstein J, Gonzalez A, Grabarits C, Greenberg S, Gress D, Gu E, Hall C, Hernandez F, Hoesch R, Hoh B, Houser J, Hu R, Huang Y, Hussain M, Insinga S, Jadhav A, Jaffe J, Jahromi B, Jallo J, James M, James R, Jankowitz B, Jeon E, Jichici D, Jonczak K, Jonker B, Karlen N, Keric N, Kerz T, Knopman J, Koenig C, Krishnamurthy S, Kumar A, Kureshi I, Laidlaw J, Lakhanpal A, Latorre J, Leifer D, Leiphart J, Lenington S, Li Y, Lopez G, Lovick D, Lumenta C, Luo J, Maas M, MacDonald J, MacKenzie L, Madan V, Majkowski R, Major O, Malhorta R, Malkoff M, Mangat H, Maswadeh A, Matouk C, McArthur K, McCaul S, Medow J, Mezey G, Mighty J, Miller D, Mohan K, Muir K, Muñoz L, Nakaji P, Nee A, Nekoovaght-Tak S, Nyquist P, O'Kane R, Okasha M, O'Kelly C, Ostapkovich N, Pandey A, Parry-Jones A, Perla K, Pollack A, Polster S, Pouratian N, Quinn T, Rajajee V, Reddy K, Rehman M, Reimer R, Rincon F, Rybinnik I, Sanchez B, Sansing L, Schneck M, Schuerer L, Schul D, Schweitzer J, Seder D, Seyfried D, Sheth K, Spiotta A, Stechison M, Szabo K, Tamayo G, Tanczos K, Taussky P, Terry J, Testai F, Thomas K, Thompson C, Thompson G, Torner J, Tran H, Tucker K, Ungar L, Varelas P, Vargas N, Vatter H, Venkatasubramanian C, Vermillion K, Vollmer D, Wang Y, Wang Y, Wen J, Whitworth L, Willis B, Wrencher M, Wright S, Xu Y, Yanase L, Yi X, Yu Z, Zomorodi A (2019) Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet 393(10175):1021–1032PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Helmy A, Timofeev I, Santarius T, Hutchinson P (2010) The utility of randomised control trials in neurosurgery. A response to “equipoise and randomisation in surgery”. Br J Neurosurg 24(1):98–99CrossRef Helmy A, Timofeev I, Santarius T, Hutchinson P (2010) The utility of randomised control trials in neurosurgery. A response to “equipoise and randomisation in surgery”. Br J Neurosurg 24(1):98–99CrossRef
24.
Zurück zum Zitat Hemkens L, Contopoulos-Ioannidis D, Ioannidis J (2016) Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey. BMJ:i493 Hemkens L, Contopoulos-Ioannidis D, Ioannidis J (2016) Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey. BMJ:i493
25.
Zurück zum Zitat Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T, Rogers W, Cook J, Kolias A, Agha R, Dahm P, Sedrakyan A, McCulloch P (2019) No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations. Ann Surg 269(2):211–220CrossRefPubMed Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T, Rogers W, Cook J, Kolias A, Agha R, Dahm P, Sedrakyan A, McCulloch P (2019) No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations. Ann Surg 269(2):211–220CrossRefPubMed
26.
Zurück zum Zitat Hyam J, Pereira E, McCulloch P, Javed S, Plaha P, Mooney L, Forrow B, Joint C, Whone A, Gill S, Glasziou P, Aziz T, Green A (2015) Implementing novel trial methods to evaluate surgery for essential tremor. Br J Neurosurg 29(3):334–339CrossRefPubMed Hyam J, Pereira E, McCulloch P, Javed S, Plaha P, Mooney L, Forrow B, Joint C, Whone A, Gill S, Glasziou P, Aziz T, Green A (2015) Implementing novel trial methods to evaluate surgery for essential tremor. Br J Neurosurg 29(3):334–339CrossRefPubMed
27.
Zurück zum Zitat Kelly M, Malone D, Okun M, Booth J, Machado A (2014) Barriers to investigator-initiated deep brain stimulation and device research. Neurology 82(16):1465–1473PubMedPubMedCentralCrossRef Kelly M, Malone D, Okun M, Booth J, Machado A (2014) Barriers to investigator-initiated deep brain stimulation and device research. Neurology 82(16):1465–1473PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Khachane A, Philippou Y, Hirst A, McCulloch P (2018) Appraising the uptake and use of the IDEAL framework and recommendations: a review of the literature. Int J Surg 57:84–90CrossRefPubMed Khachane A, Philippou Y, Hirst A, McCulloch P (2018) Appraising the uptake and use of the IDEAL framework and recommendations: a review of the literature. Int J Surg 57:84–90CrossRefPubMed
29.
Zurück zum Zitat Kolias A, Chari A, Santarius T, Hutchinson P (2014) Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10(10):570–578CrossRefPubMed Kolias A, Chari A, Santarius T, Hutchinson P (2014) Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10(10):570–578CrossRefPubMed
30.
Zurück zum Zitat Kolias A, Adams H, Timofeev I, Czosnyka M, Corteen E, Pickard J, Turner C, Gregson B, Kirkpatrick P, Murray G, Menon D, Hutchinson P (2016) Decompressive craniectomy following traumatic brain injury: developing the evidence base. Br J Neurosurg 30(2):246–250PubMedPubMedCentralCrossRef Kolias A, Adams H, Timofeev I, Czosnyka M, Corteen E, Pickard J, Turner C, Gregson B, Kirkpatrick P, Murray G, Menon D, Hutchinson P (2016) Decompressive craniectomy following traumatic brain injury: developing the evidence base. Br J Neurosurg 30(2):246–250PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Kolias A, Viaroli E, Rubiano A, Adams H, Khan T, Gupta D, Adeleye A, Iaccarino C, Servadei F, Devi B, Hutchinson P (2018) The current status of decompressive craniectomy in traumatic brain injury. Current Trauma Reports 4(4):326–332PubMedPubMedCentralCrossRef Kolias A, Viaroli E, Rubiano A, Adams H, Khan T, Gupta D, Adeleye A, Iaccarino C, Servadei F, Devi B, Hutchinson P (2018) The current status of decompressive craniectomy in traumatic brain injury. Current Trauma Reports 4(4):326–332PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Kolias A, Marcus H, Broekman M, Hutchinson P, McCulloch P (2019) Surgery for intracerebral haemorrhage. The Lancet 394(10199):e21CrossRef Kolias A, Marcus H, Broekman M, Hutchinson P, McCulloch P (2019) Surgery for intracerebral haemorrhage. The Lancet 394(10199):e21CrossRef
33.
Zurück zum Zitat Latouche E, Arena C, Ivey J, Garcia P, Pancotto T, Pavlisko N, Verbridge S, Davalos R, Rossmeisl J (2018) High-frequency irreversible electroporation for intracranial meningioma: a feasibility study in a spontaneous canine tumor model. Technology in Cancer Research & Treatment 17:153303381878528CrossRef Latouche E, Arena C, Ivey J, Garcia P, Pancotto T, Pavlisko N, Verbridge S, Davalos R, Rossmeisl J (2018) High-frequency irreversible electroporation for intracranial meningioma: a feasibility study in a spontaneous canine tumor model. Technology in Cancer Research & Treatment 17:153303381878528CrossRef
34.
Zurück zum Zitat Májovský M, Netuka D, Beneš V, Kucera P (2019) Burr-hole evacuation of chronic subdural hematoma: biophysically and evidence-based technique improvement. Journal of Neurosciences in Rural Practice 10(1):113PubMedPubMedCentralCrossRef Májovský M, Netuka D, Beneš V, Kucera P (2019) Burr-hole evacuation of chronic subdural hematoma: biophysically and evidence-based technique improvement. Journal of Neurosciences in Rural Practice 10(1):113PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Marcus H, Hughes-Hallett A, Kwasnicki R, Darzi A, Yang G, Nandi D (2015) Technological innovation in neurosurgery: a quantitative study. J Neurosurg 123(1):174–181PubMedPubMedCentralCrossRef Marcus H, Hughes-Hallett A, Kwasnicki R, Darzi A, Yang G, Nandi D (2015) Technological innovation in neurosurgery: a quantitative study. J Neurosurg 123(1):174–181PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Marcus H, Choi D, Dorward N (2017) Letter to the editor. da Vinci robot-assisted transoral surgery for sellar tumors. J Neurosurg 127(4):961–962PubMedCrossRef Marcus H, Choi D, Dorward N (2017) Letter to the editor. da Vinci robot-assisted transoral surgery for sellar tumors. J Neurosurg 127(4):961–962PubMedCrossRef
37.
Zurück zum Zitat Marcus H, Williams S, Hughes-Hallett A, Camp S, Nandi D, Thorne L (2017) Predicting surgical outcome in patients with glioblastoma multiforme using pre-operative magnetic resonance imaging: development and preliminary validation of a grading system. Neurosurg Rev 40(4):621–631PubMedPubMedCentralCrossRef Marcus H, Williams S, Hughes-Hallett A, Camp S, Nandi D, Thorne L (2017) Predicting surgical outcome in patients with glioblastoma multiforme using pre-operative magnetic resonance imaging: development and preliminary validation of a grading system. Neurosurg Rev 40(4):621–631PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Marcus H, Vakharia V, Ourselin S, Duncan J, Tisdall M, Aquilina K (2018) Robot-assisted stereotactic brain biopsy: systematic review and bibliometric analysis. Childs Nerv Syst 34(7):1299–1309PubMedPubMedCentralCrossRef Marcus H, Vakharia V, Ourselin S, Duncan J, Tisdall M, Aquilina K (2018) Robot-assisted stereotactic brain biopsy: systematic review and bibliometric analysis. Childs Nerv Syst 34(7):1299–1309PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Marcus H, Vakharia V, Sparks R, Rodionov R, Kitchen N, McEvoy A, Miserocchi A, Thorne L, Ourselin S, Duncan J (2019) Computer-assisted versus manual planning for stereotactic brain biopsy: retrospective comparative pilot study. J Neurol Neurosurg Psychiatry 90(3):e5.3–e5e4CrossRef Marcus H, Vakharia V, Sparks R, Rodionov R, Kitchen N, McEvoy A, Miserocchi A, Thorne L, Ourselin S, Duncan J (2019) Computer-assisted versus manual planning for stereotactic brain biopsy: retrospective comparative pilot study. J Neurol Neurosurg Psychiatry 90(3):e5.3–e5e4CrossRef
40.
Zurück zum Zitat Martin E, Muskens I, Senders J, DiRisio A, Karhade A, Zaidi H, Moojen W, Peul W, Smith T, Broekman M (2019) Randomized controlled trials comparing surgery to non-operative management in neurosurgery: a systematic review. Acta Neurochir 161(4):627–634CrossRefPubMed Martin E, Muskens I, Senders J, DiRisio A, Karhade A, Zaidi H, Moojen W, Peul W, Smith T, Broekman M (2019) Randomized controlled trials comparing surgery to non-operative management in neurosurgery: a systematic review. Acta Neurochir 161(4):627–634CrossRefPubMed
41.
Zurück zum Zitat McCulloch P, Altman D, Campbell W, Flum D, Glasziou P, Marshall J, Nicholl J (2009) No surgical innovation without evaluation: the IDEAL recommendations. Lancet 374(9695):105–1112CrossRef McCulloch P, Altman D, Campbell W, Flum D, Glasziou P, Marshall J, Nicholl J (2009) No surgical innovation without evaluation: the IDEAL recommendations. Lancet 374(9695):105–1112CrossRef
42.
Zurück zum Zitat McCulloch P, Cook J, Altman D, Heneghan C, Diener M (2013) IDEAL framework for surgical innovation 1: the idea and development stages. BMJ 346(jun18 3):f3012–f3012PubMedPubMedCentralCrossRef McCulloch P, Cook J, Altman D, Heneghan C, Diener M (2013) IDEAL framework for surgical innovation 1: the idea and development stages. BMJ 346(jun18 3):f3012–f3012PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Moojen W, Peul W (2015) Minimally invasive surgery for lumbar spinal stenosis. BMJ 350(apr01 5):h1664CrossRefPubMed Moojen W, Peul W (2015) Minimally invasive surgery for lumbar spinal stenosis. BMJ 350(apr01 5):h1664CrossRefPubMed
44.
Zurück zum Zitat Moojen W, Bredenoord A, Viergever R, Peul W (2014) Scientific evaluation of spinal implants. Spine 39(26):2115–2118CrossRefPubMed Moojen W, Bredenoord A, Viergever R, Peul W (2014) Scientific evaluation of spinal implants. Spine 39(26):2115–2118CrossRefPubMed
45.
Zurück zum Zitat Mortini P (2014) Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas. Endocrine 47(2):415–420CrossRefPubMed Mortini P (2014) Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas. Endocrine 47(2):415–420CrossRefPubMed
46.
Zurück zum Zitat Mortini P, Barzaghi L, Albano L, Panni P, Losa M (2017) Microsurgical therapy of pituitary adenomas. Endocrine 59(1):72–81CrossRefPubMed Mortini P, Barzaghi L, Albano L, Panni P, Losa M (2017) Microsurgical therapy of pituitary adenomas. Endocrine 59(1):72–81CrossRefPubMed
47.
Zurück zum Zitat Muskens I, Broekman M (2017) Innovation in neurosurgery—response to: “IDEAL”, the operating microscope, and the parachute. Acta Neurochir 160(2):369–370CrossRefPubMed Muskens I, Broekman M (2017) Innovation in neurosurgery—response to: “IDEAL”, the operating microscope, and the parachute. Acta Neurochir 160(2):369–370CrossRefPubMed
48.
Zurück zum Zitat Muskens I, Diederen S, Senders J, Zamanipoor Najafabadi A, van Furth W, May A, Smith T, Bredenoord A, Broekman M (2017) Innovation in neurosurgery: less than IDEAL? A systematic review. Acta Neurochir 159(10):1957–1966CrossRefPubMed Muskens I, Diederen S, Senders J, Zamanipoor Najafabadi A, van Furth W, May A, Smith T, Bredenoord A, Broekman M (2017) Innovation in neurosurgery: less than IDEAL? A systematic review. Acta Neurochir 159(10):1957–1966CrossRefPubMed
49.
Zurück zum Zitat Muskens I, Senders J, Dasenbrock H, Smith T, Broekman M (2017) The Woven EndoBridge device for treatment of intracranial aneurysms: a systematic review. World Neurosurgery 98:809–817.e1CrossRefPubMed Muskens I, Senders J, Dasenbrock H, Smith T, Broekman M (2017) The Woven EndoBridge device for treatment of intracranial aneurysms: a systematic review. World Neurosurgery 98:809–817.e1CrossRefPubMed
50.
Zurück zum Zitat Muskens I, Broekman M, Lycklama à Nijeholt G, Moojen W (2019) Letter: Food and drug administration approval of the Woven EndoBridge device: what do the numbers tell us? Neurosurgery 85(3):E619–E620CrossRefPubMed Muskens I, Broekman M, Lycklama à Nijeholt G, Moojen W (2019) Letter: Food and drug administration approval of the Woven EndoBridge device: what do the numbers tell us? Neurosurgery 85(3):E619–E620CrossRefPubMed
51.
Zurück zum Zitat Nerland U, Jakola A, Solheim O, Weber C, Rao V, Lonne G, Solberg T, Salvesen O, Carlsen S, Nygaard O, Gulati S (2015) Minimally invasive decompression versus open laminectomy for central stenosis of the lumbar spine: pragmatic comparative effectiveness study. BMJ 350(apr01 1):h1603PubMedPubMedCentralCrossRef Nerland U, Jakola A, Solheim O, Weber C, Rao V, Lonne G, Solberg T, Salvesen O, Carlsen S, Nygaard O, Gulati S (2015) Minimally invasive decompression versus open laminectomy for central stenosis of the lumbar spine: pragmatic comparative effectiveness study. BMJ 350(apr01 1):h1603PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Radic J, Illes J, McDonald P (2019) Fetal repair of open neural tube defects: ethical, legal, and social issues. Camb Q Healthc Ethics 28(3):476–487CrossRefPubMed Radic J, Illes J, McDonald P (2019) Fetal repair of open neural tube defects: ethical, legal, and social issues. Camb Q Healthc Ethics 28(3):476–487CrossRefPubMed
53.
Zurück zum Zitat Rushton P, Siddique I, Crawford R, Birch N, Gibson M, Hutton M (2017) Magnetically controlled growing rods in the treatment of early-onset scoliosis. The Bone & Joint Journal 99-B(6):708–713CrossRef Rushton P, Siddique I, Crawford R, Birch N, Gibson M, Hutton M (2017) Magnetically controlled growing rods in the treatment of early-onset scoliosis. The Bone & Joint Journal 99-B(6):708–713CrossRef
54.
Zurück zum Zitat Sala F, Skinner S, Arle J, Constantini S, Deletis V, Kothbauer K, MacDonald D, Shils J, Soto F, Szelenyi A (2018) Letter: guidelines for the use of electrophysiological monitoring for surgery of the human spinal column and spinal cord. Neurosurgery 83(2):E82–E84CrossRefPubMed Sala F, Skinner S, Arle J, Constantini S, Deletis V, Kothbauer K, MacDonald D, Shils J, Soto F, Szelenyi A (2018) Letter: guidelines for the use of electrophysiological monitoring for surgery of the human spinal column and spinal cord. Neurosurgery 83(2):E82–E84CrossRefPubMed
55.
Zurück zum Zitat Sciacca S, Smith J, Akram H, Asim A, Matharu M, Watkins L (2014) Rechargeable occipital nerve stimulator systems: a patient satisfaction study. Br J Neurosurg 28(5):645–649CrossRefPubMed Sciacca S, Smith J, Akram H, Asim A, Matharu M, Watkins L (2014) Rechargeable occipital nerve stimulator systems: a patient satisfaction study. Br J Neurosurg 28(5):645–649CrossRefPubMed
56.
Zurück zum Zitat Sedrakyan A, Campbell B, Merino J, Kuntz R, Hirst A, McCulloch P (2016) IDEAL-D: a rational framework for evaluating and regulating the use of medical devices. BMJ:2372 Sedrakyan A, Campbell B, Merino J, Kuntz R, Hirst A, McCulloch P (2016) IDEAL-D: a rational framework for evaluating and regulating the use of medical devices. BMJ:2372
57.
Zurück zum Zitat Tradewell M, Albersheim J, Dahm P (2019) Use of the IDEAL framework in the urological literature: where are we in 2018? BJU Int 123(6):1078–1085CrossRefPubMed Tradewell M, Albersheim J, Dahm P (2019) Use of the IDEAL framework in the urological literature: where are we in 2018? BJU Int 123(6):1078–1085CrossRefPubMed
58.
Zurück zum Zitat Vakharia V, Rodionov R, McEvoy A, Miserocchi A, Sparks R, O’Keeffe A, Ourselin S, Duncan J (2018) Improving patient safety during introduction of novel medical devices through cumulative summation analysis. J Neurosurg 130(1):213–219PubMedPubMedCentralCrossRef Vakharia V, Rodionov R, McEvoy A, Miserocchi A, Sparks R, O’Keeffe A, Ourselin S, Duncan J (2018) Improving patient safety during introduction of novel medical devices through cumulative summation analysis. J Neurosurg 130(1):213–219PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat van Essen T, den Boogert H, Cnossen M, de Ruiter G, Haitsma I, Polinder S, Steyerberg E, Menon D, Maas A, Lingsma H, Peul W (2018) Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study. Acta Neurochir 161(3):435–449CrossRefPubMed van Essen T, den Boogert H, Cnossen M, de Ruiter G, Haitsma I, Polinder S, Steyerberg E, Menon D, Maas A, Lingsma H, Peul W (2018) Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study. Acta Neurochir 161(3):435–449CrossRefPubMed
60.
Zurück zum Zitat Versteeg A, van der Velden J, Hes J, Eppinga W, Kasperts N, Verkooijen H, Oner F, Seravalli E, Verlaan J (2018) Stereotactic radiotherapy followed by surgical stabilization within 24 h for unstable spinal metastases; a stage I/IIa study according to the IDEAL framework. Frontiers in Oncology:8 Versteeg A, van der Velden J, Hes J, Eppinga W, Kasperts N, Verkooijen H, Oner F, Seravalli E, Verlaan J (2018) Stereotactic radiotherapy followed by surgical stabilization within 24 h for unstable spinal metastases; a stage I/IIa study according to the IDEAL framework. Frontiers in Oncology:8
61.
Zurück zum Zitat Waqas M, Vakhari K, Weimer P, Hashmi E, Davies J, Siddiqui A (2019) Safety and effectiveness of embolization for chronic subdural hematoma: systematic review and case series. World Neurosurgery 126:228–236CrossRefPubMed Waqas M, Vakhari K, Weimer P, Hashmi E, Davies J, Siddiqui A (2019) Safety and effectiveness of embolization for chronic subdural hematoma: systematic review and case series. World Neurosurgery 126:228–236CrossRefPubMed
62.
Zurück zum Zitat Weber C, Jakola A, Gulati S, Nygaard Ø, Solheim O (2013) Evidence-based clinical management and utilization of new technology in European neurosurgery. Acta Neurochir 155(4):747–754CrossRefPubMed Weber C, Jakola A, Gulati S, Nygaard Ø, Solheim O (2013) Evidence-based clinical management and utilization of new technology in European neurosurgery. Acta Neurochir 155(4):747–754CrossRefPubMed
64.
Zurück zum Zitat Williams M (2011) No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency. Arch Neurol 68(12):1510CrossRefPubMed Williams M (2011) No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency. Arch Neurol 68(12):1510CrossRefPubMed
65.
Zurück zum Zitat Zaki M, Cote D, Muskens I, Smith T, Broekman M (2018) Defining innovation in neurosurgery: results from an international survey. World Neurosurgery 114:e1038–e1048CrossRefPubMed Zaki M, Cote D, Muskens I, Smith T, Broekman M (2018) Defining innovation in neurosurgery: results from an international survey. World Neurosurgery 114:e1038–e1048CrossRefPubMed
66.
Zurück zum Zitat Zakrzewska J, Akram H (2011) Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database Syst Rev Zakrzewska J, Akram H (2011) Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database Syst Rev
Metadaten
Titel
The IDEAL framework in neurosurgery: a bibliometric analysis
verfasst von
Helen C. U. Ota
Brandon G. Smith
Alexander Alamri
Faith C. Robertson
Hani Marcus
Allison Hirst
Marike Broekman
Peter Hutchinson
Peter McCulloch
Angelos Kolias
Publikationsdatum
10.07.2020
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 12/2020
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-020-04477-5

Weitere Artikel der Ausgabe 12/2020

Acta Neurochirurgica 12/2020 Zur Ausgabe

Original Article - Neurosurgery general

Machine learning in neurosurgery: a global survey

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.